ANTIFIBROTIC EFFECTS OF A POLYSACCHARIDE EXTRACTED FROM GANODERMA-LUCIDUM, GLYCYRRHIZIN, AND PENTOXIFYLLINE IN RATS WITH CIRRHOSIS INDUCED BY BILIARY OBSTRUCTION
Ej. Park et al., ANTIFIBROTIC EFFECTS OF A POLYSACCHARIDE EXTRACTED FROM GANODERMA-LUCIDUM, GLYCYRRHIZIN, AND PENTOXIFYLLINE IN RATS WITH CIRRHOSIS INDUCED BY BILIARY OBSTRUCTION, Biological & pharmaceutical bulletin, 20(4), 1997, pp. 417-420
For the past few years, we have been investigating polysaccharides fro
m Ganoderma lucidum as antifibrotic agents. In a previous study, we di
scovered that polysaccharides extracted from G. lucidum lowered the co
llagen content in liver but had no effect on serum biochemical paramet
ers in rats subjected to bile duct ligation and scission-induced fibro
sis. In this study, we changed the extraction method and obtained poly
saccharides extracted from G. lucidum. The polysaccharide from G. luci
dum reduced the serum aspartate transaminase (AST), alanine transamina
se (ALT), alkaline phosphatase (ALP) and total bilirubin and also redu
ced the collagen content in liver and improved the morphology. Pentoxi
fylline, which is reported to exhibit an antifibrotic effect in pigs w
ith fibrosis induced by yellow phosphorus, did not have any antifibrot
ic effects in fibrosis induced by biliary obstruction. Glycyrrhizin, w
hich is used in the treatment of hepatitis, reduced serum ALT and AST
values but there was no significance. It had no effect on liver hydrox
yproline content,which implies that glycyrrhizin has no antifibrotic e
ffect in the rats with fibrosis induced by bile duct ligation and scis
sion. These data suggest that the polysaccharide from Ganoderma lucidu
m could be a promising antifibrotic agent. However, further study is n
eeded to understand the inhibition mechanism of collagen deposition of
polysaccharides from Ganoderma lucidum and its clinical applicability
remains to be established.